|
Total properties:
16
|
|
|
|
Patent #:
|
|
Issue Dt:
|
12/04/2012
|
Application #:
|
11852106
|
Filing Dt:
|
09/07/2007
|
|
Publication #:
|
|
Pub Dt:
|
06/12/2008
| | | | |
|
Title:
|
HUMANIZED ANTI-CD19 ANTIBODIES AND THEIR USE IN TREATMENT OF ONCOLOGY, TRANSPLANTATION AND AUTOIMMUNE DISEASE
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
11/11/2014
|
Application #:
|
13661138
|
Filing Dt:
|
10/26/2012
|
|
Publication #:
|
|
Pub Dt:
|
05/09/2013
| | | | |
|
Title:
|
HUMANIZED ANTI-CD19 ANTIBODIES
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
06/19/2018
|
Application #:
|
14347016
|
Filing Dt:
|
03/25/2014
|
|
Publication #:
|
|
Pub Dt:
|
04/09/2015
| | | | |
|
Title:
|
CD40L-SPECIFIC TN3-DERIVED SCAFFOLDS AND METHODS OF USE THEREOF
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
02/20/2018
|
Application #:
|
14509457
|
Filing Dt:
|
10/08/2014
|
|
Publication #:
|
|
Pub Dt:
|
05/26/2016
| | | | |
|
Title:
|
HUMANIZED ANTI-CD19 ANTIBODIES AND THEIR USE IN TREATMENT OF ONCOLOGY, TRANSPLANTATION AND AUTOIMMUNE DISEASE
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
08/31/2021
|
Application #:
|
15993964
|
Filing Dt:
|
05/31/2018
|
|
Publication #:
|
|
Pub Dt:
|
11/01/2018
| | | | |
|
Title:
|
NUCLEIC ACIDS ENCODING A Tn3 SCAFFOLD COMPRISING A CD40L-SPECIFIC MONOMER SUBUNIT
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
07/27/2021
|
Application #:
|
16083825
|
Filing Dt:
|
09/10/2018
|
|
Publication #:
|
|
Pub Dt:
|
10/29/2020
| | | | |
|
Title:
|
ILT7 BINDING MOLECULES AND METHODS OF USING THE SAME
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
04/19/2022
|
Application #:
|
16097573
|
Filing Dt:
|
10/29/2018
|
|
Publication #:
|
|
Pub Dt:
|
01/02/2020
| | | | |
|
Title:
|
BINDING MOLECULES SPECIFIC FOR FCGAMMA RIIA AND USES THEREOF
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
11/03/2020
|
Application #:
|
16195446
|
Filing Dt:
|
11/19/2018
|
|
Publication #:
|
|
Pub Dt:
|
10/17/2019
| | | | |
|
Title:
|
METHODS AND KITS FOR PREDICTING INFUSION REACTION RISK AND ANTIBODY-MEDIATED LOSS OF RESPONSE BY MONITORING SERUM URIC ACID DURING PEGYLATED URICASE THERAPY
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
08/04/2020
|
Application #:
|
16202743
|
Filing Dt:
|
11/28/2018
|
|
Publication #:
|
|
Pub Dt:
|
10/17/2019
| | | | |
|
Title:
|
VARIANT FORMS OF URATE OXIDASE AND USE THEREOF
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16455073
|
Filing Dt:
|
06/27/2019
|
|
Publication #:
|
|
Pub Dt:
|
02/20/2020
| | | | |
|
Title:
|
PURIFICATION OF PROTEINS WITH CATIONIC SURFACTANT
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16796525
|
Filing Dt:
|
02/20/2020
|
|
Publication #:
|
|
Pub Dt:
|
01/21/2021
| | | | |
|
Title:
|
METHODS OF TREATING A PULMONARY BACTERIAL INFECTION USING FLUOROQUINOLONES
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16883273
|
Filing Dt:
|
05/26/2020
|
|
Publication #:
|
|
Pub Dt:
|
03/04/2021
| | | | |
|
Title:
|
HUMANIZED ANTI-CD19 ANTIBODIES AND THEIR USE IN TREATMENT OF ONCOLOGY, TRANSPLANTATION AND AUTOIMMUNE DISEASE
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/31/2022
|
Application #:
|
16911074
|
Filing Dt:
|
06/24/2020
|
|
Publication #:
|
|
Pub Dt:
|
03/18/2021
| | | | |
|
Title:
|
VARIANT FORMS OF URATE OXIDASE AND USE THEREOF
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
11/29/2022
|
Application #:
|
16969774
|
Filing Dt:
|
08/13/2020
|
|
Publication #:
|
|
Pub Dt:
|
01/07/2021
| | | | |
|
Title:
|
ANTIBODIES TO FELINE MCDONOUGH SARCOMA (FMS)-LIKE TYROSINE KINASE 3 RECEPTOR LIGAND (FLT3L) AND USES THEREOF FOR TREATING AUTOIMMUNE AND INFLAMMATORY DISEASES
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17006075
|
Filing Dt:
|
08/28/2020
|
|
Publication #:
|
|
Pub Dt:
|
07/29/2021
| | | | |
|
Title:
|
USE OF AEROSOLIZED LEVOFLOXACIN FOR TREATING CYSTIC FIBROSIS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/02/2023
|
Application #:
|
17036110
|
Filing Dt:
|
09/29/2020
|
|
Publication #:
|
|
Pub Dt:
|
06/17/2021
| | | | |
|
Title:
|
METHODS AND KITS FOR PREDICTING INFUSION REACTION RISK AND ANTIBODY-MEDIATED LOSS OF RESPONSE BY MONITORING SERUM URIC ACID DURING PEGYLATED URICASE THERAPY
|
|
